A PHASE I TRIAL OF HYPOFRACTIONATED STEREOTACTIC IRRADIATION (HFSRT) WITH PEMBROLIZUMAB AND BEVACIZUMAB IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA (NCT02313272)

被引：0
|
作者：
Sahebjam, Solmaz [1 ]
Forsyth, Peter [1 ]
Arrington, John [1 ]
Jaglal, Michael [1 ]
Tran, Nam D. [1 ]
Etame, Arnold B. [1 ]
Wicklund, Melissa [1 ]
Drury-Sibiga, Ali [1 ]
Long, Wendy [1 ]
Evernden, Brittany [1 ]
Gatewood, Tyra [1 ]
Macaulay, Robert [1 ]
Chinnaiyan, Prakash [2 ,3 ]
Yu, Michael [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Beaumont Hlth, Dept Radiat Oncol, Royal Oak, MI USA
[3] Oakland Univ, Sch Med, Royal Oak, MI USA
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ATIM-18
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [1] A PHASE I TRIAL OF HYPOFRACTIONATED STEREOTACTIC IRRADIATION (HFSRT) WITH PEMBROLIZUMAB
    Sahebjam, Solmaz
    Johnstone, Peter A.
    Forsyth, Peter
    Arrington, John
    Jaglal, Michael
    Tran, Nam D.
    Vrionis, Frank D.
    Etame, Arnold B.
    Wicklund, Melissa
    Elie, Anise L.
    Gatewood, Tyra
    Macaulay, Robert
    Chinnaiyan, Prakash
    Yu, Michael
    [J]. NEURO-ONCOLOGY, 2016, 18 : 21 - 21
  • [2] Nivolumab combined with hypofractionated stereotactic irradiation (HFSRT) for patients with recurrent high grade gliomas: A phase I trial (NCT02829931).
    Sahebjam, Solmaz
    Forsyth, Peter A. J.
    Arrington, John
    Tran, Nam D.
    Jaglal, Michael Vishal
    Mokhtari, Sepideh
    Long, Wendy
    Macaulay, Robert J.
    Wicklund, Melissa
    Drury-Sibiga, Ali
    Gatewood, Tyra
    Robinson, Timothy J.
    Raval, Raju R.
    Yu, Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] A PHASE I TRIAL OF HYPOFRACTIONATED STEREOTACTIC IRRADIATION (HFSRT) COMBINED WITH NIVOLUMAB (NIVO), IPILIMUMAB (IPI) AND BEVACIZUMAB (BEV) IN PATIENTS (PTS) WITH RECURRENT HIGH GRADE GLIOMAS
    Sahebjam, Solmaz
    Forsyth, Peter
    Nam Tran
    Etame, Arnold
    Arrington, John
    Jaglal, Michael
    Mokhtari, Sepideh
    MacAulay, Robert
    Wicklund, Melissa
    Evernden, Brittany
    Gatewood, Tyra
    Robinson, Timothy
    Raval, Raju
    Yu, Michael
    [J]. NEURO-ONCOLOGY, 2019, 21 : 5 - 5
  • [4] Safety and antitumor activity of hypofractionated stereotactic irradiation (HFSRT) with pembrolizumab (Pembro) and bevacizumab (Bev) in patients (pts) with recurrent high grade gliomas: Preliminary results from phase I study.
    Sahebjam, Solmaz
    Johnstone, Peter A.
    Forsyth, Peter A. J.
    Arrington, John
    Vrionis, Frank D.
    Etame, Arnold B.
    Tran, Nam D.
    Dalvi, Pranali H.
    Kim, Sungjune
    Macaulay, Roberti
    Chinnaiyan, Prakash
    Yu, Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study
    Sahebjam, Solmaz
    Forsyth, Peter A.
    Tran, Nam D.
    Arrington, John A.
    Macaulay, Robert
    Etame, Arnold B.
    Walko, Christine M.
    Boyle, Theresa
    Peguero, Edwin N.
    Jaglal, Michael
    Mokhtari, Sepideh
    Enderling, Heiko
    Raghunand, Natarajan
    Gatewood, Tyra
    Long, Wendy
    Dzierzeski, Jennifer L.
    Evernden, Brittany
    Robinson, Timothy
    Wicklund, Melissa C.
    Kim, Sungjune
    Thompson, Zachary J.
    Chen, Dung-Tsa
    Chinnaiyan, Prakash
    Yu, Hsiang-Hsuan Michael
    [J]. NEURO-ONCOLOGY, 2021, 23 (04) : 677 - 686
  • [6] A phase I trial of hypofractionated stereotactic radiation therapy with sunitinib in recurrent high grade glioma
    Wuthrick, E. J.
    Curran, W. J.
    Lin, A.
    Glass, J.
    Evans, J.
    Andrews, D.
    Axelrod, R.
    Murphy, H.
    Werner-Wasik, M.
    Dicker, A. P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S205 - S205
  • [7] Patterns of Failure in Patients With Recurrent High-Grade Glioma Treated With Hypofractionated Stereotactic Re-rradiation, Pembrolizumab, and Bevacizumab
    Padmanabhan, R.
    Zhang, G. G.
    Oliver, D. E.
    Graham, J.
    Grass, D.
    Sahebjam, S.
    Yu, H. H. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E596 - E597
  • [8] A PHASE I TRIAL OF HYPOFRACTIONATED STEREOTACTIC RADIATION THERAPY WITH SUNITINIB IN RECURRENT HIGH-GRADE GLIOMA
    Wuthrick, Evan
    Curran, Walter
    Lin, Alexander
    Glass, Jon
    Evans, James
    Andrews, David
    Axelrod, Rita
    Pereira-Rico, Alvaro
    Murphy, Heather
    Werner-Wasik, Maria
    Dicker, Adam
    [J]. NEURO-ONCOLOGY, 2008, 10 (05) : 885 - 885
  • [9] Hypofractionated Stereotactic Reirradiation for Recurrent High-grade Glioma
    Hynkova, L.
    Slampa, P.
    Kazda, T.
    Garcic, J.
    Vrzal, M.
    Fadrus, P.
    Belanova, R.
    Sikova, I.
    Dvorak, D.
    Dolezelova, H.
    Pospisil, P.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S617 - S617
  • [10] Patterns of Failure Following Concurrent Bevacizumab and Hypofractionated Stereotactic Radiotherapy for Recurrent High-grade Glioma
    Shapiro, L. Q.
    Karimi, S.
    Gutin, P. H.
    Iwamoto, F. M.
    Zhang, Z.
    Lassman, A. B.
    Abrey, L. E.
    Beal, K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S125 - S125
12345